# Surgical Outcomes of Central Airway Adenoid Cystic Carcinoma: A Retrospective Single-Center Analysis

**Authors:** Toshihiko Soma, Shinjiro Nagai, Takashi Indo, Satoshi Ueda, Naoko Imanishi, Mitsuhiro Ueda, Yoshihiro Miyamoto

PMC · DOI: 10.5761/atcs.oa.25-00210 · Annals of Thoracic and Cardiovascular Surgery · 2026-02-18

## TL;DR

This study examines surgical outcomes for a rare airway cancer, finding that surgery with reconstruction and adjuvant therapy can provide long-term control despite risks.

## Contribution

The study provides a single-center analysis of surgical outcomes for central airway adenoid cystic carcinoma, a rare malignancy with no standard treatment.

## Key findings

- Eight patients underwent surgical resection with various airway reconstruction techniques.
- The 5-year overall survival rate was 72.9%, with two patients experiencing recurrence.
- Major complications included recurrent laryngeal nerve palsy and one fatal tracheoinnominate artery fistula.

## Abstract

Central airway adenoid cystic carcinoma (CAACC) is a rare malignancy lacking a standard treatment approach and often precluding complete resection. This study assessed the surgical outcomes of patients with CAACC treated at a single institution.

We retrospectively reviewed patients who underwent surgical resection for CAACC between September 2013 and August 2021.

Eight patients (mean age: 51.5 years) were included. Tumor locations were bronchus (n = 1), trachea (n = 4), carina and bronchus (n = 2), and carina and trachea (n = 1). Surgical procedures included sleeve lobectomy (n = 1), tracheal resection (n = 4), sleeve pneumonectomy (n = 2), and carinal resection with reconstruction (n = 1). Preoperative radiation and bronchoscopic tumor resection were performed in 1 patient each. One patient died from a postoperative tracheoinnominate artery fistula. Major complications included recurrent laryngeal nerve palsy (n = 3). Adjuvant therapy was provided for positive or uncertain margins. During a median follow-up of 6 years, 2 patients developed recurrence but remained alive at the last follow-up. The 5-year overall survival rate was 72.9%.

Surgical resection with airway reconstruction and adjuvant therapy can offer long-term disease control in CAACC, though life-threatening complications warrant careful consideration.

## Linked entities

- **Diseases:** adenoid cystic carcinoma (MONDO:0004971)

## Full-text entities

- **Diseases:** pleural (MESH:D010995), Tumor (MESH:D009369), anastomotic complications (MESH:D057868), bronchial asthma (MESH:D001249), blood loss (MESH:D016063), tracheomalacia (MESH:D055090), atelectasis (MESH:D001261), inflammation (MESH:D007249), Adenoid Cystic Carcinoma (MESH:D003528), swallowing dysfunction (MESH:D003680), blood (MESH:D006402), Recurrent laryngeal nerve injury (MESH:D061226), death (MESH:D003643), nerve injury (MESH:D000080902), tracheal stenosis (MESH:D014135), airway stenosis (MESH:D003251), airway obstruction (MESH:D000402), recurrent laryngeal nerve palsy (MESH:D014826), respiratory distress (MESH:D012128), anastomotic fistula (MESH:D005402), nerve palsy (MESH:D003389), chronic respiratory failure (MESH:D012131), tracheal tumor (MESH:D014134), asphyxiation (MESH:C537571), palsy (MESH:D010243), tracheoinnominate artery fistula (MESH:D016157)
- **Chemicals:** cisplatin/S1 (-), nivolumab (MESH:D000077594), ipilimumab (MESH:D000074324), argon (MESH:D001128)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12928833/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12928833/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12928833/full.md

---
Source: https://tomesphere.com/paper/PMC12928833